These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1231874)

  • 1. [Coenzyme A and dyslipidemia. Note II. Rapid effects of CoA on primary and secondary hypertriglyceridemias].
    Consolo F; Di Tommaso G; Arrigo F; Trifirò A
    Boll Soc Ital Biol Sper; 1975 Dec; 51(24):1927-30. PubMed ID: 1231874
    [No Abstract]   [Full Text] [Related]  

  • 2. [Coenzyme A and dyslipidemia. Note I. Rapid changes in lipid and lipoprotein levels induced with coenzyme A in humans].
    Consolo F; Di Tommaso G; Arrigo F; Trifirò A
    Boll Soc Ital Biol Sper; 1975 Dec; 51(24):1920-6. PubMed ID: 1231873
    [No Abstract]   [Full Text] [Related]  

  • 3. [Coenzyme A and dyslipidemia. Note III. Action of coenzyme A on changes in the blood lipid pattern after administration of dietary lipids].
    Consolo F; Di Tommaso G; Arrigo F; Trifirò A
    Boll Soc Ital Biol Sper; 1975 Dec; 51(24):1931-6. PubMed ID: 1231875
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preliminary studies on the effects of CoA administration on plasmatic lipids in man].
    Arrigo F; Vitale D; Consolo F
    Boll Soc Ital Biol Sper; 1973 Mar; 49(5):305-10. PubMed ID: 4786567
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preliminary research on the effects of administration of CoA on plasmatic lipids in humans].
    Arrigo F; Vitale D; Consolo F
    Clin Ter; 1974 Dec; 71(5):459-68. PubMed ID: 4452226
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of short-term treatment with coenzyme A or sulodexide on plasma lipids in patients with hypertriglyceridemia (type IV) or mixed hyperlipemia (type IIb).
    Ghidini O; Zenari L; Guilarte N; Tessari R; Tomba A
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):390-6. PubMed ID: 3525431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coenzyme A and hyperlipoproteinaemias.
    Perin A; Fraticelli G
    Int J Tissue React; 1991; 13(2):111-4. PubMed ID: 1955292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experimentation of clofibride. Apropos of 40 cases].
    Warembourg H; Jaillard J
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1292-6. PubMed ID: 4802928
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of cinnarizine in hyperlipaemic patients.
    Saba P; Galeone F; Salvadorini F; Guarguaglini M; Houben JL
    G Clin Med; 1974 Aug; 55(8):586-99. PubMed ID: 4377134
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipid lowering effects of statins and fibrates in the management of HIV dyslipidemias associated with antiretroviral therapy in HIV clinical practice.
    Visnegarwala F; Maldonado M; Sajja P; Minihan JL; Rodriguez-Barradas MC; Ong O; Lahart CJ; Hasan MQ; Balasubramanyam A; White AC
    J Infect; 2004 Nov; 49(4):283-90. PubMed ID: 15474625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the rapid effects of SAMe in primary and secondary triglyceridemias].
    Consolo F; Arrigo F; Tommaso GD; Trifirò A
    Minerva Med; 1977 Apr; 68(19):1257-61. PubMed ID: 854226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rapid changes in blood lipid parameters induced by glucuronyl glucosamine glycan sulfate in obese diabetic and hyperlipidemia patients].
    Ferlito S; La Spina E; Fichera C; Cultrera E; Patanè M; Ciulla P
    Arch Sci Med (Torino); 1982; 139(4):441-8. PubMed ID: 7168636
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of long-term treatment with fenofibrate on serum lipids and lipoproteins in patients with hypercholesterolemia and hypertriglyceridemia].
    Sznajderman M
    Pol Tyg Lek; 1986 Dec 22-29; 41(51-52):1633-7. PubMed ID: 3588382
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypolipemic effects of a new tetralin derivative: compound 13473-Su (Ciba)].
    Ciobanu V; Zălaru MC; Ciocan A; Mihăilescu S
    Stud Cercet Med Interna; 1971; 12(1):67-80. PubMed ID: 5565781
    [No Abstract]   [Full Text] [Related]  

  • 15. [Plasma tocopherol and retinol levels and their correlation with circulating lipids in dyslipidemia subjects].
    Suraci C; Di Pietro S; Audisio M
    Boll Soc Ital Biol Sper; 1986 Aug; 62(8):1017-23. PubMed ID: 3790336
    [No Abstract]   [Full Text] [Related]  

  • 16. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the effect of probucol on blood lipids].
    Giannini SD; Forti N; Ziliotto EE
    Arq Bras Cardiol; 1981 Feb; 36(2):139-42. PubMed ID: 7325835
    [No Abstract]   [Full Text] [Related]  

  • 18. [Do nitrites influence the blood lipid level?].
    Klein WW
    Med Klin; 1971 Dec; 66(50):1743-5. PubMed ID: 5003599
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipoprotein lipid alterations with cholestyramine administration.
    Jones RJ; Dobrilovic L
    J Lab Clin Med; 1970 Jun; 75(6):953-66. PubMed ID: 5421080
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cerivastatin-a new synthetic 3-hydroxy-3-methylglutaryl (HMG) inhibitor: effect of 0,2 mg dose in patients with primary hyperlipidemias].
    Solov'eva EIu; Rozhkova TA; Tvorogova MG; Kukharchuk VV
    Ter Arkh; 1999; 71(8):30-4. PubMed ID: 10515032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.